Interestingly, tumour cell CDC42 has previously been shown to confer resistance to cytotoxic lymphocytes and, in breast cancer cells, CDC42-dependent actin remodelling at the immune synapse reduces killing by natural killer cells (Al Absi et al., 2018; Marques et al., 2008). This evidence concerns the gene CDC42 and breast carcinoma.